Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy (PINPOINT)

Rutgers The State University of New Jersey

Status: Completed

Conditions: Immunotherapy; Clinical Trials

Treatments: Behavioral: PINPOINT Digital Educational Tool

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT05034289

Pro2021000072

132101

Details and patient eligibility

About

The purpose of the research is to: develop an educational website to empower Black and African American cancer patients to make informed decisions about personalized cancer treatment and clinical trials. The sample size for the qualitative interviews was (n=48) when saturation was achieved. With a goal of (n=33) for the pilot trial, the overall target sample size for the study is (n=81).

Full description

The website offers tools for discussing innovative treatments with their clinicians, finding clinical trials, and locating support groups. We are conducting key informant interviews, testing the website with pilot tester and asking volunteers from our Community Advisory Board to review our website prototype to further improve its design and features.

Enrollment: 81 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

Patient Key Informant:

• Age 18 and older
• Self-identify as Black/African American
• Diagnosed with solid tumor
• Able to read and speak English fluently
• Able to provide informed consent
• Able to complete 1 survey and an in-depth interview

Relative Key Informant:

• Age 18 and older
• Spouse, blood relative, or caregiver of a cancer patient who identifies as Black/African American
• Able to read and speak English fluently
• Able to provide informed consent
• Able to complete 1 survey and an in-depth interview

Provider Key Informant:

• Age 18 and older
• Physician, nurse, social worker, patient navigator, or financial counselor
• Work in oncology setting
• Able to read and speak English fluently
• Able to provide informed consent
• Able to complete 1 survey and an in-depth interview

Pilot Tester:

• Age 18 and older
• Self-identify as Black/African American
• Able to read and speak English fluently
• Able to provide informed consent
• Newly diagnosed with solid tumor cancer (Stage I-IV)
• Have not yet consulted with an oncologist regarding treatment
• Able to complete 2 surveys and an in-depth interview

Exclusion Criteria

Key informants will be excluded from the study if they do not meet the inclusion criteria. Pilot testers will be excluded from the study if they previously participated as key informants and do not meet inclusion criteria.

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

81 participants in 1 patient group

PINPOINT Digital Educational Tool

Experimental group

Description:

Newly diagnosed Black cancer patients will be asked to access and engage with the educational website/intervention prototype before their clinic visit or in the clinic immediately before their appointment with their treating oncologist.

Treatment:

Behavioral: PINPOINT Digital Educational Tool